Agios Pharmaceuticals, Inc.
AGIO
$33.55
$0.962.95%
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Net Income | -163.27% | -163.46% | -161.27% | -159.51% | 278.14% |
| Total Depreciation and Amortization | 1.98% | -5.75% | -8.42% | -7.22% | -12.03% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 108.72% | 106.91% | 106.45% | 105.84% | -1,610.41% |
| Change in Net Operating Assets | -53.27% | -29.49% | -67.15% | -332.80% | -82.49% |
| Cash from Operations | 11.18% | 5.24% | 4.33% | -24.54% | -32.43% |
| Capital Expenditure | -53.82% | -86.97% | -156.14% | -337.29% | -235.59% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -100.00% | -100.00% |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -100.00% | -- |
| Other Investing Activities | 89.49% | 166.77% | 131.09% | -21.65% | -33.79% |
| Cash from Investing | -6.62% | 15.49% | 3.78% | -53.17% | 32.54% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 33.35% | -10.41% | -39.93% | 4.92% | -5.46% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 33.35% | -10.41% | -39.93% | 4.92% | -5.46% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 614.83% | 187.03% | 207.74% | -185.02% | -1,451.91% |